Publication: 3481

Publication: 3481

Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL.

PubMed

DOI

Google Scholar

Citation:: Blood vol 139 (8) 1147-59

Year:: 2022
Type:: Manuscript
Funding:: AFT
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 11

Parents:: 2833 2997
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:: Bristol-Myers Squibb, Celegene
Grants:

Corr. Author:
Authors:: Peter Martin Nancy L Bartlett Julio C Chavez John L Reagan Sonali M Smith Ann S LaCasce Jeffrey Jones James Drew Chengqing Wu Erin Mulvey Maria V Revuelta Leandro Cerchietti John P Leonard

Networks:: FL065, FL310, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, NY018, RI005, TX041

Study: AFT-08
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: